At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
Midodrine HCl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 4, Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension
In Brief
A Phase 4 clinical trial evaluating Midodrine HCl and Placebo for Orthostatic Hypotension. Completed, enrolled 24 participants across 13 sites.
Detailed Summary
The purpose of this study is to determine whether midodrine works against the symptoms of orthostatic hypotension caused by being on a tilt table.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOrthostatic Hypotension
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 2012
Enrollment StartMay 2012
Primary CompletionJun 2013
TodayJul 2026
First PostedJan 26, 2012
Enrollment StartMay 14, 2012
Primary CompletionJun 22, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.4 years ago
Interventions
Midodrine HCldrug
dose at the subject's current dose level
Placebodrug
single dose of matching placebo